Target intelligence / Profile preview

MIR200C and MIR141 host gene (MIR200CHG)

Target
MIR200CHG
Molecular classification
Other (Non-coding RNA gene, microRNA host gene), miRNA cluster
01

Overview

The MIR200C and MIR141 host gene (MIR200CHG) is a non-coding RNA gene locus that gives rise to the microRNAs miR-200c and miR-141. This locus forms the miR-200c/miR-141 intergenic cluster on chromosome 12, spanning regions crucial for epithelial cell identity, epithelial-mesenchymal transition (EMT), stress response, and tumorigenesis. The primary transcript undergoes complex regulation involving DNA looping and transcriptional co-regulation with the nearby PTPN6 gene (SHP1), affecting cellular response to oxidative stress and tumorigenic stimuli[2][1]. Deregulation of miR-200c/miR-141 expression influences cancer progression, metastasis, chemosensitivity, and tissue development. While this locus itself is not a direct therapeutic target, the mature miRNAs it hosts are functional regulators with disease significance and therapeutic interest[1][2][4].

Other names
MIR200CHGMIR200C/141 host geneU47924.27MIR200C-141 genomic clustermiR-200c/miR-141 host locus
02

Mechanism of action

Not applicable for MIR200CHG itself; for miR-200c/miR-141, mechanisms include modulation of gene expression by binding target mRNAs and repressing translation (microRNA-mediated silencing)

03

Biological functions

Post-transcriptional gene regulation via miR-200c/miR-141 microRNAsRegulation of epithelial-mesenchymal transition (EMT)Cell differentiation, especially epithelial lineage commitmentOxidative stress responseModulation of cell proliferation, apoptosis
04

Disease associations

Cancer: ovarian cancer, breast cancer, renal cell carcinoma, endometrial cancerNeurodegenerative disease: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosisPathological fibrosis
05

Safety considerations

No direct safety concerns or therapeutic challenges for targeting MIR200CHG itself, but targeting miR-200 family members must account for broad regulatory roles influencing apoptosis, proliferation, and potentially off-target gene regulation
06

Interacting drugs

No directly interacting drugs with MIR200CHG; however, the miR-200c/miR-141 cluster can influence chemosensitivity and tumor response to agents like cisplatin and other DNA-amaging drugs in ovarian cancer models.

1 more in the full profile.

07

Biomarkers

Expression of miR-200c/miR-141 microRNAs as prognostic biomarkers and indicators for epithelial phenotype and cancer progressionUse in monitoring chemosensitivity and EMT status in tumors

Beyond the preview

Go deeper on MIR200C and MIR141 host gene (MIR200CHG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR200C and MIR141 host gene (MIR200CHG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call